Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life

Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment

(2014) HB Jensen et al.   Multiple Sclerosis Journal

Long-term effects of dalfampridine in patients with multiple sclerosis

(2013) T. Ruck et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance

(2013) Ilse Lamers et al.   Multiple Sclerosis Journal

Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function

(2013) Meheroz H. Rabadi et al.   Drugs in research & development

Motor Fatigue Measurement by Distance-Induced Slow Down of Walking Speed in Multiple Sclerosis

(2012) Rémy Phan-Ba et al.   PLoS One

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

(2011) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparison of the 2- and 6-minute walk test in multiple sclerosis

(2011) D Gijbels et al.   Multiple Sclerosis Journal

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

(2010) Antonio Scalfari et al.   BRAIN

Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice

(2010) Deborah M. Miller et al.   Current Neurology and Neuroscience Reports

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

Gait analysis in multiple sclerosis: Characterization of temporal–spatial parameters using GAITRite functional ambulation system

(2008) Uri Givon et al.   GAIT & POSTURE

Dose comparison trial of sustained-release fampridine in multiple sclerosis

(2008) A. D. Goodman et al.   NEUROLOGY